Table 3.

Relationship of HDL-CEC and other HDL characteristics with cIMT, stratified for normoglycemia and (pre)diabetes

HDL-characteristic (Z-Score)	Model	cIMT (Z-Score)						Pint
		NGM			IGM&T2DM
		N = 268			N = 228
		std β	95% CI	P-value	std β	95% CI	P-value
HDL-CEC	1	0.062	−0.056; 0.179	.303	−0.152	−0.286; −0.017	.028	.019
	2	0.059	−0.052; 0.170	.296	−0.132	−0.265; 0.001	.051	.023
	3	0.061	−0.044; 0.167	.255	−0.129	−0.263; 0.005	.060	.025
HDL-C	1	−0.057	−0.172; 0.058	.328	−0.181	−0.325; −0.038	.014	.184
	2	−0.035	−0.150; 0.079	.545	−0.138	−0.287; 0.012	.071	.216
	3	−0.044	−0.158; 0.070	.446	−0.138	−0.293; 0.017	.081	.169
ApoA-I	1	0.007	−0.111; 0.125	.905	−0.188	−0.325; −0.025	.007	.033
	2	0.031	−0.088; 0.149	.611	−0.132	−0.277; 0.014	.076	.075
	3	0.011	−0.105; 0.128	.848	−0.118	−0.268; 0.031	.120	.067
HDL size	1	−0.088	−0.196; 0.021	.114	−0.056	−0.207; 0.095	.465	.737
	2	−0.061	−0.172; 0.050	.279	−0.009	−0.165; 0.147	.908	.823
	3	−0.055	−0.167; 0.056	.329	−0.006	−0.170; 0.159	.947	.910
HDL-P	1	−0.007	−0.130; 0.115	.909	−0.169	−0.298; −0.039	.011	.061
	2	0.043	−0.081; 0.167	.496	−0.112	−0.253; 0.029	.118	.080
	3	0.006	− 0.115; 0.128	.919	−0.132	−0.276; 0.012	.073	.038

Std β, standardized regression coefficient.

Linear regression analyses, Model 1: crude, Model 2: adjusted for age, sex, Model 3 additionally adjusted for smoking, BMI, medication usage (antihypertensive, glucose- and lipid-lowering), physical activity, caloric intake, systolic and diastolic blood pressure, fasting plasma glucose, and glucose metabolism state.